Some PIK3R1 mutations reduce basal inhibition of catalytic subunits, usually due to disruption of the inhibitory inter-SH2 domain, and are found in cancers (Philp et al., 2001) and vascular malformations with overgrowth (Cottrell et al., 2021). Here, PIK3R1 is linked to cancer.